The phrase "disease target" is a grammatically correct and commonly used phrase in written English.
It is often used to refer to a particular organism, molecule, or process that has been identified as a potential method of treating, or slowing the progress of, a specific disease. For example, "Recent studies suggest that targeting the immune system may be a viable disease target for the treatment of rheumatoid arthritis."
The enthusiasm has also spread to the pharmaceutical industry, where cancer, once neglected, has become by some measures the most popular disease target.
Multivariate parametric images obtained by statistical modelling of the relevant parameters allow the reduction of data and a clear definition of the defined disease target.
High-throughput screening uses robots to test the actions of thousands of compounds against a molecular disease target (itself identified by genomics).
Finally, we discuss clinical trial progress of the first in kind anti-METH mAb, for which METH is the disease target instead of vulnerable central nervous system networks of receptors, binding sites, and neuronal connections.
By modifying cytomegaloviral determinants that control unconventional T cell priming it is possible to uniquely tailor the CD8+ T cell response for each individual disease target in order to maximize prophylactic or therapeutic protection.
The mutant protein, because of its improved stability and strengthened lattice interactions, thus provides a significantly improved reagent for use in structure-based drug design for this important disease target.
A UHC approach will require that individual disease targets, to some degree, become secondary to overarching health goals.
New drug for Crohn's disease targets RNA.
Researchers are making progress in new clinical indications and novel disease targets.
Severe combined immunodeficiencies (SCIDs) appear as optimal disease targets to challenge potential efficacy of gene therapy.
Many different peptidases represent disease targets and are being used in structure-based drug design approaches.
